MENU
CRSP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CRISPR Therapeutics AG (CRSP) Earnings Date & Reports
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
CRSP is expected to report earnings to fall 17.97% to -104 cents per share on November 04
Q3'26
Est.
$-1.05
Q1'26
Missed
by $0.05
Q4'25
Missed
by $0.20
Q3'25
Beat
by $0.09
Q2'25
Missed
by $1.00
The last earnings report on May 04 showed earnings per share of -127 cents, missing the estimate of -123 cents. With 697.46K shares outstanding, the current market capitalization sits at 5.12B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of gene-based medicines
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
Baarerstrasse 14
Phone
+41 415613277
Employees
393
Web
https://www.crisprtx.com